Literature DB >> 22669736

Assessment of global cardiac I-123 MIBG uptake and washout using volumetric quantification of SPECT acquisitions.

Berlinda J van der Veen1, Imad Al Younis, Albert de Roos, Marcel P M Stokkel.   

Abstract

BACKGROUND: Assessment of cardiac innervation using single-photon emission computer tomography (SPECT) is less established than planar imaging, but may be more suitable for quantification. Therefore, a volumetric quantification of I-123 MIBG SPECT acquisitions was performed. Reproducibility, the effects of extra cardiac I-123 MIBG uptake and the relation with conventional planar indices were evaluated.
METHODS: 54 patients referred for planar and SPECT I-123 MIBG acquisitions were included. Ellipsoidal or box-shaped volumes of interest were placed on the left ventricle, cardiac lumen, mediastinum, lung and liver. SPECT segmentation was performed twice in all patients. Indices were determined based on the heart-to-mediastinum (HM), myocardial wall-to-mediastinum and myocardial wall-to-lumen regions. HM ratios and washout rates were also determined based on anterior planar images.
RESULTS: Cardiac count densities were highly reproducible (CV 1.5-5.4, ICC 0.96-0.99) and inter-rater variability was low (CV 1.8-6.8, ICC 0.94-0.99). Mediastinal uptake was an important explanatory variable of uptake in the entire heart (early R(2) = 0.36; delayed R(2) =0.43) and myocardial wall (early R(2) = 0.28; delayed R(2) = 0.37). Lung washout was an explanatory variable of organ washout of the heart (heart R(2) = 0.38; myocardial wall R(2) = 0.33). In general, SPECT indices showed moderate-to-good correlations with the planar uptake (PCC 0.497-0.851).
CONCLUSION: By applying a volumetric segmentation method we were able to segment the heart in all patients. SPECT I-123 MIBG quantification was found to be highly reproducible and had a moderate to good correlation with the planar indices.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22669736      PMCID: PMC3395351          DOI: 10.1007/s12350-012-9539-4

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  31 in total

Review 1.  Cardiac neurotransmission SPECT imaging.

Authors:  Albert Flotats; Ignasi Carrió
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

Review 2.  Statistics in respiratory medicine. 2. Repeatability and method comparison.

Authors:  S Chinn
Journal:  Thorax       Date:  1991-06       Impact factor: 9.139

3.  Cardiac adrenergic innervation is affected in asymptomatic subjects with very early stage of coronary artery disease.

Authors:  Sakari Simula; Esko Vanninen; Laura Viitanen; Anu Kareinen; Seppo Lehto; Pia Pajunen; Mikko Syvänne; Jyrki Kuikka; Markku Laakso; Juha Hartikainen
Journal:  J Nucl Med       Date:  2002-01       Impact factor: 10.057

4.  Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.

Authors:  T Wakabayashi; T Nakata; A Hashimoto; S Yuda; K Tsuchihashi; M I Travin; K Shimamoto
Journal:  J Nucl Med       Date:  2001-12       Impact factor: 10.057

5.  Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT.

Authors:  A Druschky; M J Hilz; G Platsch; M Radespiel-Tröger; K Druschky; T Kuwert; B Neundörfer
Journal:  J Neurol Sci       Date:  2000-04-01       Impact factor: 3.181

6.  Vascular time-activity variation in patients undergoing ¹²³I-MIBG myocardial scintigraphy: implications for quantification of cardiac and mediastinal uptake.

Authors:  Hein J Verberne; Derk O Verschure; G Aernout Somsen; Berthe L F van Eck-Smit; Arnold F Jacobson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-02       Impact factor: 9.236

7.  Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy.

Authors:  J S Gill; G J Hunter; G Gane; A J Camm
Journal:  Am Heart J       Date:  1993-08       Impact factor: 4.749

Review 8.  Assessment of cardiac sympathetic neuronal function using PET imaging.

Authors:  Frank M Bengel; Markus Schwaiger
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

9.  Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: implications for clinical studies.

Authors:  G Aernout Somsen; Hein J Verberne; Eric Fleury; Alberto Righetti
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

10.  Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction.

Authors:  Marcus V Simões; Petra Barthel; Ichiro Matsunari; Stephan G Nekolla; Albert Schömig; Markus Schwaiger; Georg Schmidt; Frank M Bengel
Journal:  Eur Heart J       Date:  2004-04       Impact factor: 29.983

View more
  11 in total

1.  Quantification of I-123-meta-iodobenzylguanidine heart-to-mediastinum ratios: not so simple after all.

Authors:  Piotr J Slomka; Puja K Mehta; Guido Germano; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2014-07-09       Impact factor: 5.952

2.  Prediction of adverse cardiac events in dilated cardiomyopathy using cardiac T2* MRI and MIBG scintigraphy.

Authors:  Michinobu Nagao; Shingo Baba; Masato Yonezawa; Yuzo Yamasaki; Takeshi Kamitani; Takuro Isoda; Satoshi Kawanami; Yasuhiro Maruoka; Yoshiyuki Kitamura; Kohtaro Abe; Taiki Higo; Kenji Sunagawa; Hiroshi Honda
Journal:  Int J Cardiovasc Imaging       Date:  2014-10-28       Impact factor: 2.357

3.  Usefulness of the 2-year iodine-123 metaiodobenzylguanidine-based risk model for post-discharge risk stratification of patients with acute decompensated heart failure.

Authors:  Shunsuke Tamaki; Takahisa Yamada; Tetsuya Watanabe; Takashi Morita; Masato Kawasaki; Atsushi Kikuchi; Tsutomu Kawai; Masahiro Seo; Jun Nakamura; Kiyomi Kayama; Daisuke Sakamoto; Kumpei Ueda; Takehiro Kogame; Yuto Tamura; Takeshi Fujita; Keisuke Nishigaki; Yuto Fukuda; Yuki Kokubu; Masatake Fukunami
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-08       Impact factor: 10.057

4.  The impact of system matrix dimension on small FOV SPECT reconstruction with truncated projections.

Authors:  Chung Chan; Joyoni Dey; Yariv Grobshtein; Jing Wu; Yi-Hwa Liu; Rachel Lampert; Albert J Sinusas; Chi Liu
Journal:  Med Phys       Date:  2016-01       Impact factor: 4.071

5.  Uptake Index of 123I-metaiodobenzylguanidine Myocardial Scintigraphy for Diagnosing Lewy Body Disease.

Authors:  Yoshito Kamiya; Satoru Ota; Shintaro Okumiya; Kosuke Yamashita; Akihiro Takaki; Shigeki Ito
Journal:  Asia Ocean J Nucl Med Biol       Date:  2017

6.  Assessment of right ventricular sympathetic dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy: An 123I-metaiodobenzylguanidine SPECT/CT study.

Authors:  Andrei Todica; Johannes Siebermair; Julia Schiller; Mathias J Zacherl; Wolfgang P Fendler; Steffen Massberg; Peter Bartenstein; Clemens C Cyran; Stefan Kääb; Marcus Hacker; Reza Wakili; Sebastian Lehner
Journal:  J Nucl Cardiol       Date:  2018-12-17       Impact factor: 5.952

7.  Quality and utility of [123I]I-metaiodobenzylguanidine cardiac SPECT imaging in nondiabetic postinfarction heart failure patients qualified for implantable cardioverter defibrillator.

Authors:  Anna Teresińska; Olgierd Woźniak; Aleksander Maciąg; Jacek Wnuk; Jarosław Jezierski; Aneta Fronczak; Elżbieta Katarzyna Biernacka
Journal:  Ann Nucl Med       Date:  2021-05-23       Impact factor: 2.668

8.  Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction.

Authors:  Shunsuke Tamaki; Takahisa Yamada; Takashi Morita; Yoshio Furukawa; Masato Kawasaki; Atsushi Kikuchi; Tsutomu Kawai; Masahiro Seo; Makoto Abe; Jun Nakamura; Kyoko Yamamoto; Kiyomi Kayama; Masatsugu Kawahira; Kazuya Tanabe; Kunpei Ueda; Takanari Kimura; Daisuke Sakamoto; Yuto Tamura; Takeshi Fujita; Masatake Fukunami
Journal:  ESC Heart Fail       Date:  2020-04-03

9.  Development of an 123I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease.

Authors:  Yoshito Kamiya; Satoru Ota; Yuta Tanaka; Kosuke Yamashita; Akihiro Takaki; Shigeki Ito
Journal:  Asia Ocean J Nucl Med Biol       Date:  2018

10.  Iodine-123-metaiodobenzylguanidine cardiac SPECT imaging in the qualification of heart failure patients for ICD implantation.

Authors:  Anna Teresińska
Journal:  J Nucl Cardiol       Date:  2018-04-25       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.